Effect of pH on Stability of Recombinant Botulinum Serotype A Vaccine in Aqueous Solution and During Storage of Freeze-Dried Formulations

被引:15
作者
Roy, Shouvik [1 ]
Henderson, Ian [2 ]
Nayar, Rajiv
Randolph, Theodore W. [3 ]
Carpenter, John F. [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Denver, CO 80262 USA
[2] CSC Co, DynPort Vaccine Co LLC, Frederick, MD 21702 USA
[3] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA
关键词
rBoNTA(H-c); pH; lyophilization;
D O I
10.1002/jps.21409
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this study was to evaluate the importance of prelyophilization solution pH on the stability of botulinum neurotoxin, serotype A (rBoNTA(H-c)). This understanding is of significant importance for proteins such as rBoNTA(H-c), a potential constituent of a multivalent vaccine product. For multivalent vaccines it may be difficult to identify a liquid formulation satisfying the stability requirements for all constituent protein antigens. Consequently, a lyophilized multivalent vaccine formulation may be a more viable alternative. Therefore evaluating the effect of prelyophilization pH (may be suboptimal) on the stability of antigens such as rBoNTA(H-c) during lyophilization/storage becomes important. We hypothesize that when rBoNTA(H-c) is lyophilized from a suboptimal pH, using the appropriate stabilizers can provide adequate physicochemical stability during lyophilization and long-term storage. We identified pH 5 and 8 in which the protein was stable and unstable against aggregation. Excipients were identified that could stabilize rBoNTA(H-c) during lyophilization and storage in a stable solution of pH 5. These excipients were 7.5% (w/v) trehalose and 2.5% (w/v) trehalose with 2.5% (w/v) HES, with and without 0.01% (w/v) polysorbate 20. In support of our hypothesis, these excipients were found to provide adequate physicochemical stability to rBoNTA(H-c) during lyophilization/storage, when freeze-dried from a prelyophilized solution of pH 8. (c) 2008 Wiley-Liss. Inc. and the American Pharmacists Association J Pharm Sci 97:5132-5146, 2008
引用
收藏
页码:5132 / 5146
页数:15
相关论文
共 36 条
[1]   Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state [J].
Anchordoquy, TJ ;
Carpenter, JF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 332 (02) :231-238
[2]  
Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P2081
[3]   Development of vaccines for prevention of botulism [J].
Byrne, MP ;
Smith, LA .
BIOCHIMIE, 2000, 82 (9-10) :955-966
[4]   Rational design of stable lyophilized protein formulations: Some practical advice [J].
Carpenter, JF ;
Pikal, MJ ;
Chang, BS ;
Randolph, TW .
PHARMACEUTICAL RESEARCH, 1997, 14 (08) :969-975
[5]   Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist [J].
Chang, BS ;
Reeder, G ;
Carpenter, JF .
PHARMACEUTICAL RESEARCH, 1996, 13 (02) :243-249
[6]  
CHANG BS, 2002, RATIONAL DESIGN STAB
[7]  
Cherington M, 1998, MUSCLE NERVE, V21, P701, DOI 10.1002/(SICI)1097-4598(199806)21:6<701::AID-MUS1>3.0.CO
[8]  
2-B
[9]   Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation [J].
Chi, EY ;
Krishnan, S ;
Randolph, TW ;
Carpenter, JF .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1325-1336
[10]   Botulinum toxins in neurological disease [J].
Comella, CL ;
Pullman, SL .
MUSCLE & NERVE, 2004, 29 (05) :628-644